TITLE

Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies

AUTHOR(S)
Papanikolaou, Panagiotis N.; Christidi, Georgia D.; Ioannidis, John P. A.
PUB. DATE
February 2006
SOURCE
CMAJ: Canadian Medical Association Journal;2/28/2006, Vol. 174 Issue 5, p635
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract Background Information on major harms of medical interventions comes primarily from epidemiologic studies performed after licensing and marketing. Comparison with data from large-scale randomized trials is occasionally feasible. We compared evidence from randomized trials with that from epidemiologic studies to determine whether they give different estimates of risk for important harms of medical interventions. Methods We targeted well-defined, specific harms of various medical interventions for which data were already available from large-scale randomized trials ({beta} 4000 subjects). Nonrandomized studies involving at least 4000 subjects addressing these same harms were retrieved through a search of MEDLINE. We compared the relative risks and absolute risk differences for specific harms in the randomized and nonrandomized studies. Results Eligible nonrandomized studies were found for 15 harms for which data were available from randomized trials addressing the same harms. Comparisons of relative risks between the study types were feasible for 13 of the 15 topics, and of absolute risk differences for 8 topics. The estimated increase in relative risk differed more than 2-fold between the randomized and nonrandomized studies for 7 (54%) of the 13 topics; the estimated increase in absolute risk differed more than 2-fold for 5 (62%) of the 8 topics. There was no clear predilection for randomized or nonrandomized studies to estimate greater relative risks, but usually (75% [6/8]) the randomized trials estimated larger absolute excess risks of harm than the nonrandomized studies did. Interpretation Nonrandomized studies are often conservative in estimating absolute risks of harms. It would be useful to compare and scrutinize the evidence on harms obtained from both randomized and nonrandomized studies.
ACCESSION #
20256877

 

Related Articles

  • Analysis and Reporting of Factorial Trials: A Systematic Review. McAlister, Finlay A.; Straus, Sharon E.; Sackett, David L.; Altman, Douglas G. // JAMA: Journal of the American Medical Association;5/21/2003, Vol. 289 Issue 19, p2545 

    Context: Although factorial trials have become common, standards for the analysis and reporting of such trials have not been established and, despite concerns about the possibility of unrecognized interactions between therapies in factorial trials, the magnitude of this potential problem is...

  • Clinic-epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. Barreto, Josafá G.; Salgado, Claudio G. // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p237 

    Background: Mycobacterium leprae is the only pathogenic bacteria able to infect peripheral nerves. Neural impairment results in a set of sensitive, motor and autonomic disturbances, with ulcers originating primarily on the hands and feet. The study objectives were to analyze the...

  • Ataxia Rating Scales-Psychometric Profiles, Natural History and Their Application in Clinical Trials. Saute, Jonas; Donis, Karina; Serrano-Munuera, Carmen; Genis, David; Ramirez, Luís; Mazzetti, Pilar; Pérez, Luis; Latorre, Pilar; Sequeiros, Jorge; Matilla-Dueñas, Antoni; Jardim, Laura // Cerebellum;Jun2012, Vol. 11 Issue 2, p488 

    We aimed to perform a comprehensive systematic review of the existing ataxia scales. We described the disorders for which the instruments have been validated and used, the time spent in its application, its validated psychometric properties, and their use in studies of natural history and...

  • Modern-Day Clinical Course of Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Experience. Nathan, David M.; Zinman, Bernard; Cleary, Patricia A.; Backlund, Jye-Yu C.; Nathan, D. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA260 

    The article discusses a study on the clinical course of type 1 diabetes mellitus. The study describes clinical care, metabolic results and the long-term complications and outcomes that can be expected with current diabetes therapy. There was a decrease in mean A1C in patients treated with...

  • Assessing observational studies of medical treatments. Hartz, Arthur; Bentler, Suzanne; Charlton, Mary; Lanska, Douglas; Butani, Yogita; Soomro, G. Mustafa; Benson, Kjell // Emerging Themes in Epidemiology;2005, Vol. 2, p8 

    Background: Previous studies have assessed the validity of the observational study design by comparing results of studies using this design to results from randomized controlled trials. The present study examined design features of observational studies that could have influenced these...

  • Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment. Marur, Shanthi; Forastiere, Arlene A. // Mayo Clinic Proceedings;Apr2008, Vol. 83 Issue 4, p489 

    Head and neck cancers account for less than 5% of all cancers and for less than 3% of all cancer deaths In the United States. The populations at risk for head and neck cancers are those who have a long-standing history of smoking and alcohol use. More recently, the Incidence of oropharyngeal...

  • Sirion introduces topical ophthalmic pain drug.  // PharmaWatch: CNS;Nov2008, Vol. 7 Issue 11, p15 

    The article reports on the proclamation made by Sirion Therapeutics Inc. regarding the availability of Durezol 0.05%. It relates that Durezol is a topical ophthalmic corticosteroid suggested for the treatment of inflammation and pain associated with ocular surgery. Furthermore, the company also...

  • Medical news.  // Mayo Clinic Health Letter;Aug2003, Vol. 21 Issue 8, p6 

    Offers suggestions on how to sort reliable medical news from less reliable report. Laboratory experiments; Epidemiologic research; Randomized controlled clinical trials. INSET: The final analysis..

  • A controlled trial of the effectiveness of a diabetes education programme in a multi-ethnic community in Glasgow [ISRCT28317455]. Baradaran, Hamid R.; Knill-Jones, Robin P.; Wallia, Sunita; Rodgers, Alison // BMC Public Health;2006, Vol. 6, p134 

    Background: Epidemiologic data have shown that the prevalence of Type 2 diabetes varies with ethnic origin. Type 2 diabetes is up to four times more common in British South Asians than in the indigenous white population. The aim of this study was to develop a culturally appropriate educational...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics